FDA Inspection
Octapharma Plasma IncOctapharma Plasma Inc – FDA Inspection, Sep 30, 2010
Record Details
This FDA Inspection record concerns Octapharma Plasma Inc, with an inspection on September 30, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma Inc
- Inspection Date
- September 30, 2010
- Product Type
- Biologics
View Company Profile
ID · 0b328cda-9d43-40b9-91c4-0a8caadff993
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 685909
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 630.40(a)Notification
- 21 CFR 630.40(a)Supplemental results
- 21 CFR 606.100(b)(21)Donor notification
- 21 CFR 606.100(b)(1)Donor criteria
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2025 | Not classified | Los Angeles District Office | |
| June 9, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 5, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 12, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma Inc
- FDA Inspection 1252471 - 2025-01-16
- FDA Inspection 1017592 - 2017-06-09
- FDA Inspection 937941 - 2015-08-05
- FDA Inspection 827645 - 2013-04-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.